A - EEA & CIS PHARMA VENTURES

254900LQDYQL5XFOQD73

The entity

Status: Active
LEI status: Lapsed - not renewed
Category: Fund
Legal form: 8888
Jurisdiction: Cyprus
Entity created: May 7, 2018

Address

Country: Cyprus
Legal address: Vyzantiou, 15, 1st Floor, Office 101, Chryseleousa, Strovolos2064 NICOSIACyprus (CY-01)
Head office: C/O BYRON CAPITAL PARTNERS LTD, 113 PRODROMOU AVENUE, OFFICE 201, STROVOLOS2064 NICOSIACyprus (CY-01)

Identifier

LEI: 254900LQDYQL5XFOQD73
Registered: April 16, 2020 at 01:45 PM UTC
Last updated: March 17, 2025 at 01:30 PM UTC
Next renewal: March 16, 2025 at 01:45 PM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Cyprus Securities and Exchange Commission (RA000162)
Identifier: AIF39_1
Verified against: Cyprus Securities and Exchange Commission (RA000162)
Verified as: AIF39_1
Corroboration: Confirmed against a public register
GLEIF conformity: Does not meet the standard

Corporate structure

Owned by

BYRON CAPITAL PARTNERS LTD
Fund managerCyprus254900LC86MWAE9V0I70
Develo Venture AIF V.C.I.C. Plc
Umbrella fundCyprus254900GL35JGZ7KUHZ10

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/254900LQDYQL5XFOQD73This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search